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1. Introduction
More than 100 years ago, Paul Ehlrich, 
the founder of chemotherapy, already 
postulated the creation of “magic bullets” 
in order to use them in the fight against 
human diseases.[1] Later, in the late 1950s, 
this idea was recovered by Richard Fey-
nman, whom proposed the possibility 
of using nanorobots as tiny “surgeons” 
capable of navigating inside the human 
body, locating damaged cells or tissues, 
and “fixing” them as needed.[2] This origi-
nally considered “wild idea” has quickly 
evolved from the speculative realm of sci-
ence fiction stories to become the main 
research area in many laboratories across 
the world. Different kinds of “nanosur-
geons” or “nanorobots” are being inves-
tigated nowadays such as those based 
on inorganic nanoparticles, bacteria and 
virus, DNA structures, etc.[3–6] In par-
ticular, in the last decades, much of the 
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work has been focused on the use of magnetic nanoparticles 
as theranostic nanorobots, especially in the field of cancer 
detection and treatment.[7–10] These nanoparticles can be easily 
synthesized in the laboratory and they present a series of prom-
ising characteristics for their use as nanorobots. Their small 
size (5–100 nm) allows them to interact with cancer cells, their 
biocompatibility (e.g., iron oxide nanoparticles) minimizes 
adverse reactions when introduced inside the human body, and 
most important, their magnetic properties can be employed 
to manipulate them remotely and make them actuate when 
in the tumor area.[11,12] In this way, novel strategies based on 
the use of magnetic nanoparticles have emerged for improving 
the detection of tumors (magnetic resonance imaging contrast 
agents, magnetic particle imaging, etc.) and their elimination 
(drug delivery, mechanical nanoactuation, magnetic hyper-
thermia, photothermia, etc.)[9,13–16]
Despite all this research, we are still, unfortunately, far from a 
standardized clinical implementation of magnetic nanoparticles. 
There are several issues and limitations that are intrinsic to the 
nature of these nanoparticles, such as their lack of self-propelled 
mobility and environment sensing mechanisms, their tendency to 
become agglomerated inside the tumors, their low targeting effi-
ciency when injected intravenously, the difficulties for removing 
them from the body after the treatment is finished, etc. In order 
to overcome these and other difficulties, different alternative 
nanorobots have been proposed in the last few years. Among 
them, the idea of using biological entities such as virus or bacteria 
to interact with tumors has been gaining momentum.[17,18]
In a recent article by Forbes,[19] it was stated that the perfect 
cancer therapy nanorobots should be able to perform several 
important functions: target tumors, produce and/or trans-
port cytotoxic molecules, self-propel, sense the local environ-
ment and be detectable, etc. Bacteria in general have biological 
mechanisms to perform these functions: flagella to self-propel, 
specific regions to respond to external signals, chemotaxis 
receptors, machinery to produce detectable molecules, etc. but 
they lack the magnetic response and actuation properties that 
have made magnetic nanoparticles so attractive for biomedical 
applications in general and cancer treatment in particular.
Fortunately, there is a particular group of bacteria that com-
bine the best of both worlds: the so-called “Magnetotactic bac-
teria” (see Figure 1).[20,21] Magnetotactic bacteria are aquatic 
microorganisms that swim along the Earth’s magnetic field 
lines using chains of nanoparticles biomineralized internally 
(called magnetosomes) as compass. The different species of 
magnetotactic bacteria synthesize chains of perfectly stoi-
chiometric magnetite nanocrystals, with genetically controlled 
sizes and shapes, surrounded by a biocompatible membrane. 
Since the magnetotactic bacteria can sense magnetic fields, 
they can be externally detected, manipulated and guided, and 
they can also be potentially used for both detection and treat-
ment of cancer through MRI, magnetic hyperthermia, or drug 
delivery.[22–26] Moreover, magnetotactic bacteria prefer to live 
in low oxygen concentration regions in water. Since the tumor 
area is low in oxygen, targeting tumors with these bacteria 
becomes easier and more efficient than with nanoparticles or 
with other bacteria. Therefore, magnetotactic bacteria present 
themselves as the paradigm of efficient nanorobots for cancer 
treatment. We will refer to them as “nanobiots.”
In the last years, a few groups have started to investigate the 
possibility of using magnetotactic bacteria as nanobiots for 
cancer treatment.[23,24,27,28] These groups have focused mainly on 
tracking and analyzing the movement of bacteria in different envi-
ronments,[29] studying the potential penetration of bacteria into 
tumors,[30] developing novel magnetic systems to remotely control 
and guide these bacteria,[31] analyzing their biocompatibility and 
navigation in blood stream,[32] etc. The initial results have been 
very positive and there have already been in vivo tests demon-
strating the efficiency of these bacteria in tumors targeting.[22]
In the present work, we want to test magnetotactic bacteria as 
nanobiots for cancer treatment by analyzing their performance as 
magnetic hyperthermia agents. Magnetic hyperthermia is a pro-
cess in which controlled heating of magnetic nanoparticles located 
in the tumor can kill or deactivate cancer cells.[13,33,34] The superior 
magnetic properties of magnetosomes in magnetic hyperthermia 
have already been reported.[35,36] However, the number of works on 
magnetic hyperthermia performance of the “whole” magnetotactic 
bacteria is very limited. Song et al.[37] found that magnetotactic 
bacteria under an external alternating magnetic field (AMF) can be 
used to kill Staphylococcus aureus, a common hospital and house-
hold pathogen. And Alphandéry et al.[26] showed that intact bacte-
rial cells containing chains of magnetosomes exhibit high specific 
absorption rates (SARs) of 625 W g−1 at 880 Oe and 108 kHz.
Although the initial results seem promising, a more thor-
ough analysis is necessary in order to fully harness the power 
of magnetotactic bacteria in the fight against cancer. Therefore, 
we have carried out a comprehensive study of the hyperthermic 
response of Magnetospirillum gryphiswaldense MSR-1 strain 
under different conditions: AC field and frequency, alignment 
of the bacteria, medium viscosity, etc. Their heating efficiency 
has been measured using both calorimetric and AC mag-
netometry methods.[33,38] The combination of both techniques 
is quite unusual, due to the lack of commercial systems that 
can carry out AC magnetometry hyperthermia, and has allowed 
us not only to check the performance of magnetotactic bac-
teria as heating agents (calorimetric method) but also to better 
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Figure 1. Description of the features that a medical nanorobot must exhibit for cancer treatment and the characteristics of a magnetotactic bacterium 
functionalized with anticancer drugs.
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understand the mechanisms behind their heating efficiency 
and how to optimize it (AC magnetometry). Our experimental 
results reveal that these bacteria exhibit superb heating effi-
ciency, close to that expected for an “ideal” heating mediator, 
provided their alignment with the magnetic field is efficiently 
controlled. In addition, we have also studied the internalization, 
the cytotoxicity, and the effect of the hyperthermia treatment of 
these bacteria in the presence of A549 human lung carcinoma 
cells, finding that magnetotactic bacteria can be efficiently 
internalized by cancer cells, exhibiting very low cytotoxicity 
and affecting the cell proliferation after magnetic hyperthermia 
treatment. To the best of our knowledge, this is the first time 
that such a thorough experimental study has been carried out.
2. Results and Discussion
As depicted in Figure 2, M. gryphiswaldense MSR-1 bacteria pre-
sent spirillum shape (2–5 µm length and 0.5 µm width), with a 
long chain of magnetosomes inside. It has been reported that 
their small size allow these bacteria to navigate through blood 
vessels, penetrate in tumors, and interact with them.[30,39] In 
addition, the inset shows that these bacteria have a flagellum at 
each end of their body, which allows them to propel in liquid 
media at speeds often exceeding 25 µm s−1.[40] These characteris-
tics are ideal for their use as nanobiots for cancer treatment. The 
magnetic response of magnetotactic bacteria has also been char-
acterized in our previous works.[41] The magnetization versus 
temperature curves present a well-defined Verwey transition 
around 110 K, which is a clear cut indicator of the stoichiometric 
magnetite structure of magnetosomes, the low dispersion on 
their size, and thereby, of their enhanced magnetic response.
2.1. Magnetic Hyperthermia
The main idea in hyperthermia mediated treatment of cancer 
is that, by raising the temperature of cancer cells up to a “ther-
apeutical window” typically between 40 and 44 °C, they can 
be deactivated (dead or driven to apoptosis) without affecting 
the healthy tissue. This is possible because in this range of 
temperatures, cancer cells have been shown to be more suscep-
tible to heat than healthy ones.[13] In addition, it has also been 
shown that by rising the temperature cancer cells become more 
susceptible to radio or chemotherapy[42,43] thus improving the 
efficiency of these therapies. If we raise the temperature up to 
values higher than 50 °C, a more violent (and less safe) cancer 
cell death is induced through thermal ablation.[44]
In Magnetic Hyperthermia, the heating of the nanoparticles 
is produced by applying an alternating magnetic field with a 
define amplitude, H, and frequency, f. As reported before, the 
heating efficiency of our bacteria has been measured by calori-
metric and AC magnetometry methods.
Calorimetric measurements (Figure 3) carried out at 300 kHz 
in water clearly indicate that magnetotactic bacteria can raise 
the temperature of the medium easily reaching the therapeutic 
window in just 3 min, by applying AC fields ≥300 Oe (initial 
body temperature, 37 °C). Below 200 Oe, the heating is prac-
tically negligible for the bacteria concentration used (≈9 × 109 
bacteria mL−1 ≈ 0.15 mgFe3O4 mL−1). This suggests that mag-
netotactic bacteria can be used as efficient heating agents by 
applying high enough AC fields. If a more drastic destruction 
of the cancer cells through thermal ablation was desired, higher 
fields and longer exposure times would let us increase the tem-
perature above 50 °C (thermal ablation), as shown in Figure 3 
(although safety limits for maximum field applicable should be 
taken into consideration[45]).
Once the magnetotactic bacteria are inside the tumor area, 
their movement would be more restricted than in the blood ves-
sels or in water, as in the previous results. In order to investigate 
how this would affect their heating properties, we have repeated 
the magnetic hyperthermia measurements this time in a more 
viscous medium, made of water with 2% agar. Moreover, we 
have also compared how the heating in this viscous medium 
varies if the bacteria are randomly dispersed or aligned par-
allel to the applied magnetic field. The corresponding heating 
curves are also presented in Figure 3.
We can see that, when the bacteria are in the 2% agar 
medium and aligned parallel to the AC field, the obtained 
heating curves are very similar to those previously measured 
in water. This suggests that the bacteria in water align in the 
direction of the applied field, as expected due to magnetotaxis 
effect. However, heating rates decrease when the bacteria are 
randomly oriented and cannot align with the field. This indi-
cates that in order to optimize the heating of magnetotactic bac-
teria for their use as hyperthermic nanobiots, they need to be 
as aligned as possible in the direction of the AC field during 
the hyperthermia treatment. Despite this, it must be remarked 
that even when the bacteria are randomly oriented, we can also 
reach temperatures inside the tumor within the therapeutic 
window for AC fields ≥300 Oe at 300 kHz.
In order to compare the heating efficiency of magnetotactic 
bacteria with those reported in the literature for other similar 
Small 2019, 15, 1902626
Figure 2. TEM image of the chain of magnetosomes inside 
M. gryphiswaldense MSR-1 bacteria. A histogram with the size distribution 
of magnetosomes has been included. In the inset, the whole bacteria are 
shown, and their flagella are indicated with blue arrows.
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Figure 3. Left column: Heating curves, Temp versus time; right column: AC hysteresis loops, M versus H, of magnetotactic bacteria in water, 2% 
agar aligned, and 2% agar random, measured at AC fields 0–600 Oe and 300 kHz. In addition, the SAR values obtained from the heating curves and 
hysteresis loops are also represented.
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magnetic nanosystems, we can calculate the so-called “spe-
cific absorption rate (SAR)” or “specific loss power (SLP).” The 
heating efficiency or SAR is directly related to the initial slope 
of the heating curves[46]
SAR s
n
p
m
m
C
T
t
=
∆
∆  (1)
where Cp is the specific heat of the solvent, ms is the mass of 
the solvent, mn is the mass of the nanoparticles, and ΔT/Δt is 
the initial slope of the heating curves (as obtained from the 
linear fitting of the heating curves during the first few seconds). 
As can be seen in Figure 3, the obtained SAR values reach over 
2000 W g−1 for the highest AC field amplitude applied (600 Oe) 
and a frequency of 300 kHz.
It is clear from these hyperthermia measurements that the 
alignment plays an important role in the heating efficiency of 
our magnetotactic bacteria. In order to better understand the 
role of the alignment and the mechanisms behind the high 
heating efficiency of our bacteria, we have also carried out AC 
magnetometry measurements. In AC magnetometry, the AC 
hysteresis loops are measured, and the heating efficiency is 
directly obtained from the area of the loops (hysteresis losses). 
This means that, essentially, the bigger the area of the AC 
loops, the better the heating efficiency. Therefore, it is easy to 
realize that the optimum shape of the AC loops in order to 
maximize the hysteresis losses would be a rectangular shape 
with high squareness, i.e., high coercivity and remanence. 
Computer simulations carried out by different groups[47–49] 
suggest that aligned chain-like structures of magnetic nanopar-
ticles, exhibiting a well-defined anisotropy axis, could give rise 
to AC loops that resemble this optimum shape. This has also 
been supported by the experimental results obtained in highly 
anisotropic nanostructures, such as magnetite nanorods.[50] 
Unfortunately, assembling this kind of chains and preventing 
them from collapsing is not an easy task, due to, among other 
factors, the presence of attractive magnetic interactions between 
chains. To this respect, magnetotactic bacteria present a clear 
advantage: they already present a stable chain of magnetosomes, 
and since these magnetic chains are “embedded” inside the bac-
teria (see Figure 2), they are efficiently separated by the bacterial 
mass, thereby avoiding the effect of magnetic interactions.
The AC hysteresis loops measured for MSR-1 bacteria have 
been represented in Figure 3. There are several interesting 
things to point out concerning the evolution of the AC loops. 
With increasing field, the AC loops evolve from the typical 
lancet shape of a minor loop at H ≤ 100 Oe (extremely narrow, 
with low squareness and low maximum magnetization), to a 
rectangular loop, for H ≥ 250 Oe, close to the optimum shape 
described before when the bacteria area parallel to the field. 
This confirms that bacteria, when aligned in the direction of 
the AC field, behave as an ideal magnetic hyperthermia media-
tors, supporting previous simulations. When the bacteria are 
randomly oriented the AC loops are tilted and do not saturate, 
giving rise to lower hysteresis losses. This can be related to the 
increase of the effective anisotropy field as the bacteria deviate 
from the parallel orientation.[38,50,51]
In addition, AC loops of magnetotactic bacteria dispersed in 
water greatly resemble those of oriented magnetotactic bacteria 
in agar: coercive field is virtually the same and magnetization 
remanence is only a little bit smaller in agar. This suggests 
that an AC field of hundreds of kHz acts as a very efficient 
mechanical anchor for magnetotactic bacteria: magnetization 
reversal in water is driven by intrinsic dynamical processes, 
just like in fixed (or nearly immobilized) bacteria. Small 
differences between water and agar (with oriented samples) 
would reflect basically different orientation degree. As a conse-
quence, physical rotation (Brownian relaxation) of the chain of 
magnetosomes seems to play a very minor role in the heating 
efficiency of magnetotactic bacteria. This is not surprising, 
noting that magnetosome chains are embedded inside bacteria 
whose response velocity to external fields is much lower than 
that required to follow kilohertz excitations. This feature indi-
cates that, contrary to what frequently happens with inorganic 
magnetic nanoparticles,[34] magnetotactic bacteria will still be 
able to provide high heating efficiency after penetrating and 
getting immobilized inside the tumor.
The SAR values (in W g−1), as commented before, were 
directly obtained from the area (A) of the AC hysteresis loops, 
according to Equation (2)[46]
SAR
W
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d0∫ µ

 = ⋅ = ⋅
f
c
A
f
c
M Ht t  (2)
with Mt being the instantaneous magnetization at time t, Ht 
the sinusoidal magnetic field of frequency f at time t, and c the 
magnetite weight concentration in the dispersing medium. The 
integration is done over a period of the oscillating magnetic 
field, T = 2π/f.
It must be noted that the SAR value obtained from AC 
magnetometry, ≈2400 W g−1 at 380 Oe, is appreciably higher 
than the one estimated before from the calorimetric measure-
ments, ≈1400 W g−1 at 400 Oe, both measured at a frequency 
of 300 kHz. This divergence can be easily understood con-
sidering that in the case of calorimetric measurements, we 
are deriving the heating efficiency of the nanoparticles from 
the average temperature measured in the medium. If there is 
enough concentration of magnetic material in the medium, the 
temperatures reached in the medium and on the surface of the 
nanoparticles are going to be similar. However, at low concen-
trations of magnetic material, the temperature in the medium 
is going to be lower than the one reached on the surface of the 
nanoparticles, and thereby, the SAR values obtained from meas-
uring the temperature of the medium are going to be smaller 
than those indicated by AC magnetometry measurements. In 
our case, even if the concentration of bacteria employed is rela-
tively high (9 × 109 cells mL−1), the concentration of magnetic 
material is quite small, only 0.15 mg-Fe3O4 mL−1 since these 
bacteria occupy a much larger volume than the one occupied 
by the nanoparticles. Increasing the applied field or the con-
centration of bacteria would diminish this problem. Another 
possibility would be to increase the number of chains and/
or magnetosomes per cell, something that in fact, has already 
been proved to be feasible.[52,53]
We commented before that using magnetotactic bacteria 
instead of inorganic nanoparticles for magnetic hyperthermia 
treatment had a series of advantages, mainly related to their 
capacity to self-propel, sense the local environment, be remotely 
Small 2019, 15, 1902626
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guided, etc. It is important to remark that on top of that, the 
heating efficiency we obtain from magnetotactic bacteria is 
appreciably higher than the one we would obtain from the iso-
lated magnetosomes. This can be clearly seen if we compare 
the SAR results obtained from AC magnetometry measure-
ments for both magnetotactic bacteria and isolated magneto-
somes dispersed in water, in the same conditions of magnetic 
material concentration, 0.15 mg-Fe3O4 mL−1 (see Figure 4).
Figure 4 displays the evolution of the SAR values normal-
ized by the frequency, f, for different magnetic field frequen-
cies, as a function of the applied magnetic field amplitude, H, 
for magnetotactic bacteria and magnetosomes dispersed in 
water. We can obtain relevant information based on the experi-
mental data. First of all, we see how the SAR values for both 
magnetotactic bacteria and magnetosomes increase linearly 
with the magnetic field frequency, since the normalized mag-
netic losses, SAR/f, are almost independent of the applied fre-
quency, as we had already observed in our previous work on 
isolated magnetosomes.[35] Second, the SAR values for the 
magnetosomes dispersed in water are clearly lower than those 
obtained for magnetotactic bacteria. While with magnetosomes 
we reach values of SAR/f close to 5 W g−1 kHz−1, with magne-
totactic bacteria we can reach values around 8 W g−1 kHz−1. As 
we have explained, this is originated by the easy alignment of 
the bacteria with the applied AC magnetic field, giving rise to a 
higher squareness of the hysteresis loops, as clearly depicted in 
the inset to Figure 4. And third, the evolution of the SAR curves 
as a function of the applied field for both magnetosomes and 
magnetotactic bacteria follows a similar trend, being negligible 
below a certain threshold field (which lies around 200 Oe in 
this case). As we pointed out in our previous works,[35,54] this 
is a clear hallmark of intrinsic hysteresis losses (which can 
be modeled by a Stoner–Wohlfarth approach) being the main 
mechanism of the heat production.
It must be remarked that the SAR values we are obtaining 
for these bacteria compare very well with some of the highest 
SAR values reported in the literature for iron oxide based 
nanoparticles.[34] For example, Guardia et al. reported SAR 
values of 1000 W g−1 for magnetite nanocubes measured at 
275 Oe and 325 kHz, and we are also obtaining similar SAR 
values (from calorimetric measurements) at 300 Oe and 
300 kHz.[55] This indicates that magnetotactic bacteria can 
heat as well as some of the best iron oxide based nanoparticles 
reported in the literature for magnetic hyperthermia applica-
tions. As expected, the SAR values obtained for the randomly 
oriented bacteria diminish, although they still compare well 
with most of the SAR values reported in the literature for iron 
oxide nanoparticles.[38] We also have to take into account the 
possibility that SAR values of bacteria could diminish after 
internalization in cancer cells, as has been frequently reported 
for magnetic nanoparticles.[16,33] Therefore, it is important to 
test the capability of the bacteria as hyperthermia agents in in 
vitro experiments.
Concerning the field amplitudes and frequencies we are 
applying in this study, we must clarify that in the literature 
it is usually considered that the product of the ampli-
tude × frequency should be below a certain safety limit, 
H·f ≤ 5 × 109 A m−1 s,[45] for medical applications. This would 
imply that, for example, at 150 kHz, we should not apply more 
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Figure 4. SAR normalized by the frequency, SAR/f, measurements at 
different frequencies, 149, 301, and 528 kHz, for bacteria and magnetosomes 
dispersed in water. Magnetosomes curve data has been taken from 
our previous work.[35] In the inset, AC hysteresis loops are presented 
corresponding to the bacteria (continuous line) and magnetosomes (dashed 
line) as obtained from AC magnetometry measurements (300 kHz).
Figure 5. Scheme of in vitro assay carried out to determine the potential cytotoxic effect of M. gryphiswaldense MSR-1 and the effect of hyperthermia 
treatment in human lung carcinoma cells.
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than ≈400 Oe for clinical hyperthermia, these are the conditions 
that we have used in the present work for studying the effect of 
hyperthermia treatment on lung cancer cells. This could restrict 
the heating capacity of our nanobiots, but it must be noted that 
there is still an ongoing discussion about the validity of this 
limit, and some works have suggested that, depending on the 
area of the tissue treated, the safety limit can reach values up to 
≈1010 A m−1 s−1, the same order of magnitude than most of our 
measurements.[13]
One of the most interesting advantages offered by the pos-
sibility of using AC magnetometry to measure SAR is that, as 
we have seen, it provides us with much more information in 
order to explain the experimental results. In fact, in our case, 
the measurement of the AC loops has allowed us to understand 
why the magnetic behavior of magnetotactic bacteria is ideal 
for increasing the heating efficiency during magnetic hyper-
thermia. To this day, very large efforts are being made to try 
to improve heating efficiency by controlling the synthesis tech-
niques, such as modifying the size of the particles, their shape, 
trying to improve the saturation magnetization of the particle, 
etc. In our opinion, our results clearly demonstrate that the 
biological structure of the magnetosome chain of magnetotactic 
bacteria is perfect to enhance the hyperthermia efficiency. This 
not only supports the use of these bacteria as biological nano-
biots with high efficiency for magnetic hyperthermia but also 
allows the study of the adequate parameters to increase the 
SAR values in other types of nanostructures with controlled 
arrangement.[56,57]
In addition, we would like to remark that the magnetotactic 
bacteria presented in this work have also high potential in other 
biomedical applications, such as magnetic particle imaging 
(MPI) agents. MPI is a novel medical imaging technique that 
relies on the nonlinearities of the time varying magnetiza-
tion, and high order harmonics are used to map the position 
of the magnetic nanoparticles.[58] The highly squared AC hys-
teresis loops measured for the aligned bacteria (see Figure 3) 
present a high harmonic distortion on odd harmonics (3rd, 5th, 
7th, …), thus making these magnetotactic bacteria very prom-
ising candidates for MPI. The suitability of isolated bacterial 
magnetosomes as MPI tracer has already been reported in the 
literature.[59]
2.2. Bacterial Interaction with Cancer Cells and In Vitro 
Hyperthermia Treatment
Despite the promising results exposed before, in order to use 
magnetotactic bacteria for cancer treatment we need to study 
how these agents interact with cancer cells: their cytotoxicity 
and the effect of the hyperthermia treatment on cancer cells. 
For this purpose, we have carried out an in vitro experiment 
in which we put in contact cells of M. gryphiswaldense MSR-1 
with human lung A549 carcinoma cells (Figure 5). The cel-
lular uptake of bacteria was visualized by fluorescence micros-
copy using labeled bacteria (Figure 6). This was possible due 
to the ability of the bacteria to show intrinsic red fluores-
cence when incubated with 40 × 10−6 m rhodamine 123 (red 
color, Figure 6b).[60] We also stained cells with Hoechst 33342 
(blue color, Figure 6a) to visualize their nuclei. As shown in 
Figure 6c, red bacteria are agglomerated in what could be the 
cancer cell cytoplasm, and surround the cell nuclei stained in 
Small 2019, 15, 1902626
Figure 6. Observation of human lung A549 carcinoma cells incubated 
for 4 h in the presence of M. gryphiswaldense MSR-1 using fluorescence 
microscopy. Bacteria were labeled with rhodamine and carcinoma cells 
were stained with Hoechst. a) Filter settings for Hoechst show nuclei in 
blue. b) Filter settings for rhodamine show bacteria in red. c) A merge 
image combining both filter settings. Scale bar = 10 µm.
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blue after Hoechst staining. Therefore, we can infer that bac-
teria enter the cells but not their nuclei.
The interaction of M. gryphiswaldense bacteria with carci-
noma cells was examined more closely by electron microscopy 
(Figure 7). After 24 h of contact, scanning electron microscopy 
(SEM) showed bacterial cells adhered on the cancer cell sur-
face, both isolated and forming aggregates (Figure 7A–C). To 
have a better insight on how cells internalize these bacteria, 
we made ultrathin sections and visualized them under trans-
mission electron microscopy (TEM). Figure 7 shows six steps 
of the bacterial invasion under TEM. There can be seen bac-
teria surrounded by cytoplasmic extensions (Figure 7D–F) and 
internalized bacteria located within endosome-like vesicles 
(Figure 7G–I). The bacteria could be identified because of the 
presence of magnetosomes.
The bacteria uptake process was further confirmed by mag-
netic measurements. The hysteresis loops of bacteria loaded 
carcinoma cells, M(H), along with those of sole bacteria, 
allowed a quantitative estimation of the quantity of magnetite 
incorporated by carcinoma cells. This was possible by com-
paring the measured saturation magnetization, Ms, with that 
of bulk magnetite (Ms = 92.3 A m2 kg−1). The actual mass of 
magnetite incorporated by the cells after 24 h of incubation 
was of around 8–10 pg magnetite/cell, a very small percentage 
of what was initially added to the cell culture (≈50 µg mL−1). 
Unfortunately, with such low magnetite internalization we 
could not measure any SAR value with our hyperthermia sys-
tems in order to test if cell internalization had an impact on the 
heating efficiency of bacteria as it has been reported for isolated 
magnetosomes.[16]
To determine the potential cytotoxic effect that the bac-
teria could cause in cancer cells, we checked cell viability after 
24 h and 48 h of the bacteria uptake. This was done using flow 
cytometry and Hoechst/propidium iodide staining to discrim-
inate between living and dead cells. Hoechst is a blue mem-
brane-permeable dye that links to DNA and therefore stains all 
the cell nuclei so that we can differentiate cells from other pos-
sible artefacts. Propidium iodide is a red stain that also links to 
DNA but only when the cell membrane is damaged indicating 
that those cells are no longer alive. The results of a representa-
tive experiment after 24 h of incubation are shown in Figure 8 
where dead cells (the ones that incorporate propidium iodide) 
are defined inside the frame to be differentiated from the living 
ones. The percentage of dead cells in both control and cells 
incubated for 24 h with bacteria is similar suggesting that bac-
teria do not cause a cytotoxic effect on this carcinoma cell line.
Small 2019, 15, 1902626
Figure 7. Electron micrographs of the interaction of M. gryphiswaldense with A549 carcinoma cells. A–C) SEM images showing bacteria adhered 
(in orange) on the cell surface. D–I) TEM images showing different steps of the internalization of bacteria. Yellow arrows indicate bacteria attached 
to cellular extensions D–F) and bacteria inside membrane bound vesicles in A549 cells G–I). The internalized bacteria are easily detectable in the 
cross-sections of the cells by the occurrence of associated magnetosomes.
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Combining the results from three different experiments 
we estimated the viability of the cell cultures, calculated as the 
ratio between the number of living cells and the total number 
of cells. We observed that viability is not affected with the 
uptake of Magnetospirillum bacteria as it always remained above 
95%, 48 h after the bacteria uptake. Moreover, as observed in 
Figure 9, the presence of bacteria within cells does not affect 
their ability to grow. The evolution of the number of living cells 
over time shows the same pattern in both cell cultures with 
and without internalized bacteria, and no significant differ-
ences were found in the number of living cells after 48 h of 
the bacteria uptake. Different results were reported in previous 
experiments[35] for the isolated magnetosomes from Magneto-
spirillum, which can show cytotoxicity affecting both viability 
and cell proliferation.
In the hyperthermia treatment, the bacteria loaded car-
cinoma cells were subjected to an AMF of 400 Oe and a 
frequency of 150 kHz during 45 min. A deleterious effect was 
observed immediately after AMF application. The results of 
a representative experiment are shown in Figure 10, which 
displays the propidium iodide fluorescence histograms of cells 
before and after AMF application. Before AMF application 
(Figure 10a,b) more than 98% of the cells showed low pro-
pidium iodine fluorescence level, corresponding to the cells 
that exclude propidium iodine or living cells. However, after 
AMF application (Figure 10c,d) the fluorescence histograms 
showed a bimodal distribution with a second peak in the region 
of high propidium iodine fluorescence level or dead cells. Con-
sidering the results of three independent experiments, the ratio 
of dead cells after the AMF exposure was estimated ≈20% of 
the total cells. Moreover, the cell proliferation was also strongly 
affected (see Figure 9). The growth of the cultures undergoing 
hyperthermia slowed down and at the end of the experiment, 
the number of living cells was three times lower than the 
control.
Therefore, our bacteria seem to be an interesting alterna-
tive to magnetosomes for hyperthermia treatments, since 
similar in vitro magnetic hyperthermia tests carried out with 
magnetosomes on cancer cells showed that isolated magneto-
somes, contrary to our bacteria, had no impact on cancer cell 
viability.[16]
3. Conclusions
In this work we have proven that magnetotactic bacteria of 
the species M. gryphiswaldense are very promising as magnetic 
hyperthermia agents for cancer treatment. Calorimetric meas-
urements reveal that these bacteria can increase the tempera-
ture of the medium up to the therapeutic window (40–45 °C) 
in less than 3 min by applying an external field with amplitude 
≥300 Oe and frequency 300 kHz. Precisely, the alignment of 
the bacteria with the field maximizes their heating efficiency. 
This has been clearly seen in the AC hyperthermia measure-
ments: hysteresis losses are maximized (reaching a nearly 
Figure 8. Fluorescence dot plots of Hoechst/propidium iodide stained cells obtained by flow cytometry in a representative experiment. a) Control cells. 
b) Cells after 24 h of bacteria uptake.
Figure 9. Time evolution of the number of live cells present in the culture 
after the bacteria uptake (in green) and hyperthermia treatment (in red). 
A control culture of cells without bacteria is also shown (in blue).
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optimum squared shape for the hysteresis loops) when the 
bacteria are parallel to the magnetic field. Moreover, the SAR 
values increase linearly with the magnetic field frequency, f, 
reaching a maximum SAR/f value of ≈8 W g−1 kHz−1 at 350 Oe, 
which is appreciably greater than those obtained for isolated 
magnetosomes. Finally, the internalization and cytotoxicity 
of the bacteria in human lung carcinoma cells A549 has been 
assessed. Fluorescence microscopy images reveal that bacteria 
tend to agglomerate around the cancer cells, thereby exhibiting 
targeting capacity. In addition, SEM and TEM images clearly 
reveal that M. gryphiswaldense can be effectively uptaken by 
cancer cells, being incorporated into endosome-like vesicles.
Moreover, these bacteria do not affect the viability of the cell 
cultures, and they barely disturb the cell proliferation. However, 
both viability and cell proliferation seem to be strongly affected 
by the hyperthermia treatment. All these results indicate that 
magnetotactic bacteria are promising nanobiots for cancer 
treatment.
4. Experimental Section
Bacterial Strain and Growth Conditions: M. gryphiswaldense MSR-1 
(DMSZ 6631) was employed in this work. The strain was cultured 
in a standard medium as described elsewhere.[61] The medium was 
enriched with iron by adding 100 × 10−6 m of Fe(III)-citrate. Cultures 
were carried out in three-fourths 1 L bottles at 28 °C without shaking 
for 120 h, when well-formed magnetosomes are observed. For all our 
studies the whole cells were employed. The bacteria were harvested by 
centrifugation, suspended in phosphate buffered saline (PBS), and fixed 
in 2% glutaraldehyde.
Transmission Electron Microscopy: Electron microscopy was 
performed on unstained cells adsorbed onto 300 mesh carbon-coated 
copper grids. TEM images were obtained with a JEOL JEM-1400 Plus 
electron microscope at an accelerating voltage of 120 kV. The particle 
size distribution was analyzed using a standard software for digital 
electron microscope image processing, ImageJ.[62] For eukaryotic cell 
visualization, these were fixed overnight with 2% glutaraldehyde in 0.1 m 
Sörenson phosphate buffer. Then, they were washed several times with 
isoosmolar phosphate/sucrose buffer, dehydrated through an acetone 
series, and embedded in Epon Polarbed resin in beam capsules that 
polymerized at 55 °C in 48 h. A Leica UCT ultramicrotome was used 
to obtain ultrathin sections of 70 nm that were finally deposited onto 
carbon-coated copper grids.[63]
Scanning Electron Microscopy: Eukaryotic cells that were incubated for 
24 h with M. gryphiswaldense were fixed with 2% glutaraldehyde in 0.1 m 
Sörenson phosphate buffer and dehydrated through increasing ethanol 
concentrations and hexamethyldisilazane. Finally, they were covered 
with gold under argon atmosphere, and visualized under the scanning 
electron microscope (Hitachi S-4800). To better differentiate between 
bacteria and cell microvilli, GIMP software was used to color the bacteria.
Magnetic Hyperthermia: Magnetic hyperthermia studies have been 
performed using a combination of calorimetric and AC magnetometry 
methods on two bacteria configurations: random and aligned. The 
calorimetric hyperthermia was carried out with a commercial 4.2 kW 
Ambrell Easyheat LI 3542 system working at fixed frequency, 300 kHz. 
Suspensions of bacteria with a total magnetite concentration of 
0.15 mgFe3O4 mL−1 in distilled water and in 2% w/v agar were used for 
measurements and the AMF was tuned from 0 to 600 Oe. The agar 
was used to restrict the physical rotation of the bacteria by increasing 
the viscosity of the medium,[49] and also to align them in different 
orientations allowing us to study the effect of the alignment on their 
heating efficiency. AC magnetometry was carried out using a homemade 
setup.[64] The AMF amplitude was tuned between 0 and 400 Oe being 
the frequency 149, 300, and 528 kHz.
Cytotoxicity Experiments and In Vitro Hyperthermia treatment: These 
experiments were performed using A549 cell line from human lung 
carcinoma cells.[65] The cell line was propagated in RPMI medium 
supplemented with 2 × 10−3 m l-glutamine, 10% fetal bovine serum, 
and a mixture of antibiotics (100 U mL−1 penicillin and 100 µg mL−1 
streptomycin) and antimycotics (0.25 µg mL−1 amphotericin B) at 37 °C 
in a humidified atmosphere (95% relative humidity) and 5% CO2. For 
the cellular uptake of bacteria, cells were seeded at 2 × 105 cells mL−1 
in culture plates with RPMI medium containing 5 × 109 bacteria mL−1 
so that the ratio bacteria/cell will be around 2.5 × 104. After 24 h of 
incubation, cells were washed to remove the excess of bacteria not 
interiorized or attached to the cell surface, and they were incubated 
again with renewed RPMI for 24 h. Cell viability was measured at 24 and 
48 h by flow cytometry on a Beckman Coulter Gallios cytometer using a 
mixture of Hoechst 33342 and propidium iodide (PI) so that dead cells 
Hoechst(+)/PI(+) could be distinguished from living cells Hoechst(+)/
PI(−). A cell culture without bacteria was incubated concurrently as a 
control. To track the uptake of bacteria, a specific assay was repeated 
using fluorescent bacteria grown in a culture medium with 40 µg mL−1 
rhodamine 123. After the incubation with the fluorescent bacteria, the 
carcinoma cells were stained with Hoechst 33342 and observed under 
a Nikon Eclipse fluorescence microscope. For in vitro hyperthermia 
treatment, bacteria-loaded cells (after 24 h in contact) were exposed to 
an AMF of 400 Oe and a frequency of 150 kHz during 45 min, and cell 
viability was checked by flow cytometer, 2 and 24 h after the exposure. 
All experiments were performed three times and data are represented as 
the mean ± standard deviation.
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Figure 10. Fluorescence histograms of A549 cells stained with propidium 
iodide obtained by flow cytometer. a) Bacteria-loaded cells at the beginning 
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